Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Inspection Finds More Tainted Blood Products (Japan)

This article was originally published in PharmAsia News

Executive Summary

Another tainted blood product has been discovered in Japan, this one extending back to the 1970s and children exposed while being treated for measles and other common diseases. The hepatitis C virus was discovered in samples of immunoglobulin preparations produced in 1977 by Green Cross, which became part of Mitsubishi Tanabe Pharma. Two samples stored since then were found to contain the virus. The supply was never tested for the disease in Japan until 1989, when the preparations were used to prevent coronary artery aneurysm in children with Kawasaki disease. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel